Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EBOS GROUP LIMITED Board/Management Information 2021

Jul 6, 2021

64813_rns_2021-07-06_b38191ce-6ad1-4bc0-a9cb-a1a405a14ae6.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [144 x 42] intentionally omitted <==

6 July 2021

NZX/ASX Code: EBO

Notification regarding director independence

EBOS Group Limited (EBOS) advises that the Board has determined that Mr Peter Williams and Mr Stuart McGregor are Independent Directors (as defined in the NZX Listing Rules).

Mr Williams and Mr McGregor were first appointed to the EBOS Board in 2013 in connection with the investment in EBOS by Sybos (an entity that is part of the Zuellig Group). Mr Williams and Mr McGregor’s associations with the Zuellig Group have changed since that time and each have no executive or non-executive roles representing Zuellig Group interests.

EBOS’ Board now comprises seven Independent Directors.

For further information please contact:

Martin Krauskopf General Manager, Mergers & Acquisitions and Investor Relations +61 3 9918 5555

Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.

About EBOS Group

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care brand owner, product marketer and distributor.